Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: A retrospective chart review
Clinical Therapeutics, 10/29/09
Hung Y–P et al. – Based on this retrospective chart review of hospitalized patients with vancomycin–induced fever, rash, or neutropenia, only 10% experienced subsequent teicoplanin–induced fever, rash, or neutropenia. However, it should be noted that half of the patients with vancomycin–induced neutropenia developed teicoplanin–induced neutropenia.
Related Articles
Therapeutic Monitoring of Vancomycin in Adults Summary of Consensus Recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
Pharmacotherapy, 10/29/09
Relevance Score: 45%
Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibiotics
Current Opinion in Infectious Diseases, 11/02/09
Relevance Score: 43%
Molecular Epidemiology of Vancomycin-Resistant Enterococcus Faecalis Among Patients of Transplantology Wards
Transplantation Proceedings, 11/12/09
Relevance Score: 42%
Aerosolized vancomycin for the treatment of MRSA after lung transplantation
Respirology, 11/10/09
Relevance Score: 42%
Evaluation of Vancomycin and Daptomycin Potency Trends against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006
Antimicrobial Agents and Chemotherapy, 10/09/09
Relevance Score: 42%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain
Journal of Orthopaedics and Traumatology, 11/24/09
Enzyme therapy in Fabry disease: severe adverse events associated with anti-agalsidase cross-reactive IgG antibodies
British Journal of Clinical Pharmacology, 11/24/09
Appraising the post-marketing safety of medicines: A description of national and international pharmacovigilance with a focus on medicines used in chronic pain
Current Anaesthesia and Critical Care, 11/24/09
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiretroviral Therapy With Heart
American Journal of Therapeutics, 11/25/09
Lopinavir Cerebrospinal Fluid Steady-State Trough Concentrations in HIV-Infected Adults
Annals of Pharmacotherapy, 11/25/09
Daptomycin Versus Other Antimicrobial Agents for the Treatment of Skin and Soft Tissue Infections: A Meta-Analysis
Annals of Pharmacotherapy, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


